Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brennan

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional classW Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Science Translational Medicine|February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoSriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Nature Medicine|September 24, 2013
CSF-1R inhibition alters macrophage polarization and blocks glioma progressionStephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Oncoimmunology|October 25, 2019
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumorsIoannis Kaffes, Frank Szulzewsky, Zhihong Chen, et al.
Cancer Discovery|March 14, 2019
Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in CancerDong Chen, Siyuan Xia, Mei Wang, et al.
Science (New York, N.Y.)|April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cellsDan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|November 30, 2025
Functional magnetic resonance imaging-guided stereotactic radiosurgery (fMRI-SRS) to avoid symptomatic radionecrosisChengcheng Gui, Mehrnaz Jenabi, Jillian Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional classW Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Science Translational Medicine|February 13, 2015
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoSriram Venneti, Mark P Dunphy, Hanwen Zhang, et al.
Nature Medicine|September 24, 2013
CSF-1R inhibition alters macrophage polarization and blocks glioma progressionStephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Oncoimmunology|October 25, 2019
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumorsIoannis Kaffes, Frank Szulzewsky, Zhihong Chen, et al.
Cancer Discovery|March 14, 2019
Mutant and Wild-Type Isocitrate Dehydrogenase 1 Share Enhancing Mechanisms Involving Distinct Tyrosine Kinase Cascades in CancerDong Chen, Siyuan Xia, Mei Wang, et al.
Science (New York, N.Y.)|April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cellsDan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2014
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastomaAntonio Omuro, Kathryn Beal, Philip Gutin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Pageof 17